Noticias de MRNA
Noticias del mercado
Últimas noticias sobre MRNA — 303 novedades recientes. Análisis, balances, opiniones y cobertura de prensa.
Moderna (MRNA) Prepares for Earnings Amid Revenue Challenges
Moderna Q1 preview: revenue rebound in focus as losses persist (MRNA:NASDAQ)
Moderna in the spotlight: Can pipeline offset earnings decline? By Investing.com
Moderna in the spotlight: Can pipeline offset earnings decline?
Moderna Inc (MRNA) Stock Price Quote Today & Current Price Chart | Capital.com UK
Discipline and Rules-Based Execution in MRNA Response
mRNA Treatment Market 2026 | Argos Therapeutics, Inc., CureVac AG, ethris GmbH, Moderna, Inc., Tiba Biotech etc.
Leading Companies Fueling Growth and Innovation in the Spikevax Market
Research Analysts Issue Forecasts for Moderna Q1 Earnings
AACR 2026: Combo therapies by Moderna, Marengo show promise in skin, breast cancer
CureVac Patent Suit Targets Moderna’s Spikevax Covid-19 Shots
Moderna shares dip amid rising selling pressure
A Moderna, Inc. (NASDAQ:MRNA - Obtenga informe gratuito) se le ha asignado una calificación promedio de "Reducir" de las veinte firmas de calificación que actualmente cubren la acción, informa MarketBeat.com. Cinco analistas de inversiones han calificado la acción con una recomendación de venta, trece han dado una recomendación de mantener
Página 9 de 16
